Summit Global Investments Amgen Inc Transaction History

Summit Global Investments

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	BUY	$229.03 - $291.01 $30,690 - $38,995	134 Added 6.17%	2,307 $606,000
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $3.31 Million - $3.73 Million	-14,731 Reduced 87.15%	2,173 $490,000
Q2 2022 Aug 23, 2022	BUY	$230.71 - $256.74 $2.04 Million - $2.27 Million	8,839 Added 109.6%	16,904 $4.11 Million
Q1 2022 Apr 29, 2022	BUY	$219.27 - $242.57 $1.77 Million - $1.96 Million	8,065 New	8,065 $1.95 Million

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

Stay updated on Summit Global Investments with notifications on news.